Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2019, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2019-07-12
DOI
10.1155/2019/8707053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural products inspired modulators of cancer stem cells-specific signaling pathways Notch and Hedgehog
- (2019) Rocco Palermo et al. CURRENT PHARMACEUTICAL DESIGN
- Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation
- (2019) Yueh-Chun Lee et al. Cancers
- A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody–drug conjugate, in patients with breast cancer and other advanced solid tumors
- (2019) Lee S. Rosen et al. INVESTIGATIONAL NEW DRUGS
- Sulforaphane Suppresses the Growth of Triple-negative Breast Cancer Stem-like Cells In vitro and In vivo
- (2019) Nadia P. Castro et al. Cancer Prevention Research
- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Notch signaling as a therapeutic target for acute lymphoblastic leukemia
- (2018) Diana Bellavia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
- (2018) Zhixian Liu et al. Translational Oncology
- The association between Notch4 expression, and clinicopathological characteristics and clinical outcomes in patients with breast cancer
- (2018) Jing‑Wei Wang et al. Oncology Letters
- NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
- (2018) Giulia Diluvio et al. Oncogenesis
- Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
- (2018) Zhe-Yu Hu et al. EBioMedicine
- Antitumor effects and mechanisms of olaparib in combination with carboplatin and BKM120 on human triple‑negative breast cancer cells
- (2018) Hui Zhao et al. ONCOLOGY REPORTS
- Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer
- (2018) Xiao-Fen Wen et al. Translational Oncology
- Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression
- (2018) Hao-Yu Lin et al. Oncogenesis
- Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells
- (2018) Ying-Sheng Xiao et al. CANCER LETTERS
- miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
- (2018) Peng Kong et al. Cell Death & Disease
- Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells
- (2018) Li Chen et al. Cell Death & Disease
- Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways
- (2018) Fokhrul Hossain et al. Frontiers in Oncology
- Targeted inhibition of Notch1 gene enhances the killing effects of paclitaxel on triple negative breast cancer cells
- (2017) Yu-Fu Zhou et al. Asian Pacific Journal of Tropical Medicine
- Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia
- (2017) Mattia Mori et al. Scientific Reports
- Breast Cancer
- (2017) Robert W. Carlson et al. Journal of the National Comprehensive Cancer Network
- Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer
- (2016) Dominic Amara et al. BREAST CANCER RESEARCH AND TREATMENT
- Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown
- (2016) Su-Hyeong Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular mechanisms of asymmetric divisions in mammary stem cells
- (2016) Angela Santoro et al. EMBO REPORTS
- Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway
- (2016) Haifeng Pei et al. FREE RADICAL BIOLOGY AND MEDICINE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun
- (2016) X Xie et al. ONCOGENE
- Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression
- (2016) G Franciosa et al. ONCOGENE
- NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
- (2016) Ying Zhong et al. OncoTargets and Therapy
- Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
- (2016) Marzia A. Locatelli et al. Oncotarget
- The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells
- (2016) Wei Huang et al. Oncotarget
- NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling
- (2016) Jianchao Zhang et al. Oncotarget
- Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
- (2016) X Zhang et al. Oncogenesis
- Therapeutic targets of triple-negative breast cancer: a review
- (2015) Vinayak S Jamdade et al. BRITISH JOURNAL OF PHARMACOLOGY
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction
- (2015) S. Zhang et al. CANCER RESEARCH
- Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population
- (2015) Neil E. Bhola et al. CANCER RESEARCH
- Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency
- (2015) W.-C. Yen et al. CLINICAL CANCER RESEARCH
- PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a -Secretase Inhibitor
- (2015) K. Wang et al. CLINICAL CANCER RESEARCH
- Therapies for triple negative breast cancer
- (2015) Eleni Andreopoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- Prognostic values of Notch receptors in breast cancer
- (2015) Junming Xu et al. TUMOR BIOLOGY
- Cripto-1 as a novel therapeutic target for triple negative breast cancer
- (2015) Nadia P. Castro et al. Oncotarget
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Juxtacrine Signaling Is Inherently Noisy
- (2014) Tomer Yaron et al. BIOPHYSICAL JOURNAL
- Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells
- (2014) Anuradha Sehrawat et al. BREAST CANCER RESEARCH AND TREATMENT
- Subtyping of triple-negative breast cancer: Implications for therapy
- (2014) Vandana G. Abramson et al. CANCER
- Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
- (2014) Mirjam C. Boelens et al. CELL
- Loss of Notch1-dependent p21Waf1/Cip1expression influences the Notch1 outcome in tumorigenesis
- (2014) Samantha Cialfi et al. CELL CYCLE
- The mammary cellular hierarchy and breast cancer
- (2014) Samantha R. Oakes et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Molecular Basis of Notch Signaling Regulation: A Complex Simplicity
- (2014) R. Palermo et al. CURRENT MOLECULAR MEDICINE
- MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis
- (2014) Chi-Hong Chao et al. JOURNAL OF CLINICAL INVESTIGATION
- Coordinate Hyperactivation of Notch1 and Ras/MAPK Pathways Correlates with Poor Patient Survival: Novel Therapeutic Strategy for Aggressive Breast Cancers
- (2014) S. Mittal et al. MOLECULAR CANCER THERAPEUTICS
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Early Specialty Palliative Care
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Notch3/Jagged1 Circuitry Reinforces Notch Signaling and Sustains T-ALL
- (2014) Maria Pelullo et al. NEOPLASIA
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Notch signaling at a glance
- (2013) K. Hori et al. JOURNAL OF CELL SCIENCE
- Therapeutic targets in triple negative breast cancer
- (2013) Sandra A O'Toole et al. JOURNAL OF CLINICAL PATHOLOGY
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
- (2013) Douglas W. McMillin et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Gamma secretase inhibitors of Notch signaling
- (2013) Clodia Osipo et al. OncoTargets and Therapy
- Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
- (2013) Cathy C. Zhang et al. Stem Cells Translational Medicine
- MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
- (2012) Xiu-juan Li et al. ARCHIVES OF MEDICAL RESEARCH
- Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
- (2012) Libero Santarpia et al. BREAST CANCER RESEARCH AND TREATMENT
- Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration
- (2012) Su-Hyeong Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
- (2012) Ming Qiu et al. CANCER LETTERS
- Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells
- (2012) Mayu Yunokawa et al. CANCER SCIENCE
- Biomarker and Pharmacologic Evaluation of the -Secretase Inhibitor PF-03084014 in Breast Cancer Models
- (2012) C. C. Zhang et al. CLINICAL CANCER RESEARCH
- Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway
- (2012) HONG PAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- DRP1-dependent mitochondrial fission initiates follicle cell differentiation duringDrosophilaoogenesis
- (2012) Kasturi Mitra et al. JOURNAL OF CELL BIOLOGY
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression
- (2012) S Cialfi et al. LEUKEMIA
- Notch and disease: A growing field
- (2012) Angeliki Louvi et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Fringe benefits: Functional and structural impacts of O-glycosylation on the extracellular domain of Notch receptors
- (2011) Nadia A Rana et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Notch-1 and Notch-4 Biomarker Expression in Triple-Negative Breast Cancer
- (2011) Jodi Speiser et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
- (2011) A. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- Notch3 in Human Breast Cancer Cell Lines Regulates Osteoblast-Cancer Cell Interactions and Osteolytic Bone Metastasis
- (2010) Zhiyuan Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of Notch and its oncogenic signaling crosstalk in breast cancer
- (2010) Shanchun Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
- (2010) Mutsuko Ibusuki et al. CANCER SCIENCE
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
- (2010) Salvatore Pece et al. CELL
- Notch-1 and Notch-4 Receptors as Prognostic Markers in Breast Cancer
- (2010) Katharine Yao et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Therapeutic antibody targeting of individual Notch receptors
- (2010) Yan Wu et al. NATURE
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
- (2010) N Turner et al. ONCOGENE
- Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival
- (2010) L. R. Perumalsamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer
- (2009) A. U. Buzdar ANNALS OF ONCOLOGY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer
- (2009) Brenda Cohen et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
- (2009) S Rasul et al. BRITISH JOURNAL OF CANCER
- Preclinical Profile of a Potent -Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
- (2009) L. Luistro et al. CANCER RESEARCH
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
- (2009) Timothy Hoey et al. Cell Stem Cell
- Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
- (2009) F. Andre et al. CLINICAL CANCER RESEARCH
- Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
- (2009) Kazuhide Watanabe et al. JOURNAL OF CELL BIOLOGY
- The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer
- (2009) Alessandra Rustighi et al. NATURE CELL BIOLOGY
- Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia
- (2009) S Checquolo et al. ONCOGENE
- Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors
- (2009) Mori ONCOLOGY REPORTS
- NOTCH3 Signaling Pathway Plays Crucial Roles in the Proliferation of ErbB2-Negative Human Breast Cancer Cells
- (2008) N. Yamaguchi et al. CANCER RESEARCH
- Transcriptome Analysis of the Normal Human Mammary Cell Commitment and Differentiation Process
- (2008) Afshin Raouf et al. Cell Stem Cell
- Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3
- (2008) Kang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The many facets of Notch ligands
- (2008) B D'Souza et al. ONCOGENE
- Notch3: from subtle structural differences to functional diversity
- (2008) D Bellavia et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started